|
1
|
Peleg AY, Seifert H and Paterson DL:
Acinetobacter baumannii: Emergence of a successful pathogen. Clin
Microbiol Rev. 21:538–582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zarrilli R, Casillo R, Di Popolo A,
Tripodi MF, Bagattini M, Cuccurullo S, Crivaro V, Ragone E, Mattei
A, Galdieri N, et al: Molecular epidemiology of a clonal outbreak
of multidrug-resistant Acinetobacter baumannii in a university
hospital in Italy. Clin Microbiol Infect. 13:481–489. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Munoz-Price LS and Weinstein RA:
Acinetobacter infection. N Engl J Med. 358:1271–1281. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dijkshoorn L, Nemec A and Seifert H: An
increasing threat in hospitals: Multidrug-resistant Acinetobacter
baumannii. Nat Rev Microbiol. 5:939–951. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gordon NC and Wareham DW:
Multidrug-resistant Acinetobacter baumannii: Mechanisms of
virulence and resistance. Int J Antimicrob Agents. 35:219–226.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alekshun MN and Levy SB: Molecular
mechanisms of antibacterial multidrug resistance. Cell.
128:1037–1050. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zavascki AP, Carvalhaes CG, Picão RC and
Gales AC: Multidrug-resistant Pseudomonas aeruginosa and
Acinetobacter baumannii: Resistance mechanisms and implications for
therapy. Expert Rev Anti Infect Ther. 8:71–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McConnell MJ, Domínguez-Herrera J, Smani
Y, Lopez-Rojas R, Docobo-Perez F and Pachon J: Vaccination with
outer membrane complexes elicits rapid protective immunity to
multidrug-resistant Acinetobacter baumannii. Infect Immun.
79:518–526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gurung M, Rho JS, Lee YC, Kim HS, Moon SY,
Yu BH, Lee JH, Jang CW, Chung SY, Cho IH, et al: Emergence and
spread of carbapenem-resistant Acinetobacter baumannii sequence
type 191 in a Korean hospital. Infect Genet Evol. 19:219–222. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ying J, Lu J, Zong L, Li A, Pan R, Cheng
C, Li K, Chen L, Ying J, Tou H, et al: Molecular epidemiology and
characterization of genotypic analysis of Acinetobacter baumannii
strains isolates from south China. Jpn J Infect Dis. 69:180–185.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sklar JG, Wu T, Gronenberg LS, Malinverni
JC, Kahne D and Silhavy TJ: Lipoprotein SmpA is a component of the
YaeT complex that assembles outer membrane proteins in Escherichia
coli. Proc Natl Acad Sci USA. 104:6400–6405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryan KR, Taylor JA and Bowers LM: The BAM
complex subunit BamE (SmpA) is required for membrane integrity,
stalk growth and normal levels of outer membrane {beta}-barrel
proteins in Caulobacter crescentus. Microbiology. 156:742–756.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lewis C, Skovierova H, Rowley G, Rezuchova
B, Homerova D, Stevenson A, Sherry A, Kormanec J and Roberts M:
Small outer-membrane lipoprotein, SmpA, is regulated by sigmaE and
has a role in cell envelope integrity and virulence of Salmonella
enterica serovar Typhimurium. Microbiology. 154:979–988. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moriel DG, Beatson SA, Wurpel DJ, Lipman
J, Nimmo GR, Paterson DL and Schembri MA: Identification of novel
vaccine candidates against multidrug-resistant Acinetobacter
baumannii. PLoS One. 8:e776312013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Batey RG: Pathogenesis of caseous
lymphadenitis in sheep and goats. Aust Vet J. 63:269–272. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jacobs AC, Hood I, Boyd KL, Olson PD,
Morrison JM, Carson S, Sayood K, Iwen PC, Skaar EP and Dunman PM:
Inactivation of phospholipase D diminishes Acinetobacter baumannii
pathogenesis. Infect Immun. 78:1952–1962. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hosseingholi EZ, Rasooli I and Gargari SL:
In silico analysis of Acinetobacter baumannii phospholipase D as a
subunit vaccine candidate. Acta Biotheor. 62:455–478. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan H, Li ML, Wan Z, Pan PH, Su XL and Hu
CP: Sequence Type 191 of Clonal Complex 92 was a Dominant
Carbapenem-Resistant Acinetobacter baumannii that Causes Nosocomial
Pneumonia in Intensive Care Units in a Teaching Hospital in Central
China. Clinical Laboratory. 62:1421–1426
|
|
19
|
Alsultan AA, Hamouda A, Evans BA and Amyes
SG: Acinetobacter baumannii: Emergence of four strains with novel
bla(OXA-51-like) genes in patients with diabetes mellitus. J
Chemother. 21:290–295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Furniss D, Gore S, Azadian B and Myers SR:
Acinetobacter infection is associated with acquired glucose
intolerance in burn patients. J Burn Care Rehabil. 26:405–408.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Metan G, Sariguzel F and Sumerkan B:
Factors influencing survival in patients with multi-drug-resistant
Acinetobacter bacteraemia. Eur J Intern Med. 20:540–544. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nacci C, Tarquinio M, de Benedictis L,
Mauro A, Zigrino A, Carratu MR, Quon MJ and Montagnani M:
Endothelial dysfunction in mice with streptozotocin-induced type 1
diabetes is opposed by compensatory overexpression of
cyclooxygenase-2 in the vasculature. Endocrinology. 150:849–861.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sheppard DC, Rieg G, Chiang LY, Filler SG,
Edwards JE Jr and Ibrahim AS: Novel inhalational murine model of
invasive pulmonary aspergillosis. Antimicrob Agents Chemother.
48:1908–1911. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Joly-Guillou ML, Wolff M, Pocidalo JJ,
Walker F and Carbon C: Use of a new mouse model of Acinetobacter
baumannii pneumonia to evaluate the postantibiotic effect of
imipenem. Antimicrob Agents Chemother. 41:345–351. 1997.PubMed/NCBI
|
|
25
|
McConnell MJ, Hanna PC and Imperiale MJ:
Cytokine response and survival of mice immunized with an adenovirus
expressing Bacillus anthracis protective antigen domain 4. Infect
Immun. 74:1009–1015. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Garcia-Quintanilla M, Pulido MR, Pachón J
and McConnell MJ: Immunization with lipopolysaccharide-deficient
whole cells provides protective immunity in an experimental mouse
model of Acinetobacter baumannii infection. PLoS One.
9:e1144102014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eveillard M, Soltner C, Kempf M,
Saint-André JP, Lemarié C, Randrianarivelo C, Seifert H, Wolff M
and Joly-Guillou ML: The virulence variability of different
Acinetobacter baumannii strains in experimental pneumonia. J
Infect. 60:154–161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McConnell MJ and Pachón J: Active and
passive immunization against Acinetobacter baumannii using an
inactivated whole cell vaccine. Vaccine. 29:1–5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bentancor LV, O'Malley JM, Bozkurt-Guzel
C, Pier GB and Maira-Litrán T: Poly-N-acetyl-β-(1–6)-glucosamine is
a target for protective immunity against Acinetobacter baumannii
infections. Infect Immun. 80:651–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McConnell MJ, Rumbo C, Bou G and Pachon J:
Outer membrane vesicles as an acellular vaccine against
Acinetobacter baumannii. Vaccine. 29:5705–5710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bentancor LV, Routray A, Bozkurt-Guzel C,
Camacho-Peiro A, Pier GB and Maira-Litrán T: Evaluation of the
trimeric autotransporter Ata as a vaccine candidate against
Acinetobacter baumannii infections. Infect Immun. 80:3381–3388.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo G, Lin L, Ibrahim AS, Baquir B,
Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA and
Spellberg B: Active and passive immunization protects against
lethal, extreme drug resistant-Acinetobacter baumannii infection.
PLoS One. 7:e294462012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Russo TA, Beanan JM, Olson R, MacDonald U,
Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR
and Campagnari AA: The K1 capsular polysaccharide from
Acinetobacter baumannii is a potential therapeutic target via
passive immunization. Infect Immun. 81:915–922. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin L, Tan B, Pantapalangkoor P, Ho T,
Hujer AM, Taracila MA, Bonomo RA and Spellberg B: Acinetobacter
baumannii rOmpA vaccine dose alters immune polarization and
immunodominant epitopes. Vaccine. 31:313–318. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fattahian Y, Rasooli I, Gargari SL
Mousavi, Rahbar MR, Astaneh S Darvish Alipour and Amani J:
Protection against Acinetobacter baumannii infection via its
functional deprivation of biofilm associated protein (Bap). Microb
Pathog. 51:402–406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Garcia-Quintanilla M, Pulido MR and
McConnell MJ: First steps towards a vaccine against Acinetobacter
baumannii. Curr Pharm Biotechnol. 14:897–902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
LaVallie ER, DiBlasio EA, Kovacic S, Grant
KL, Schendel PF and McCoy JM: A thioredoxin gene fusion expression
system that circumvents inclusion body formation in the E. coli
cytoplasm. Biotechnology (N Y). 11:187–193. 1993.PubMed/NCBI
|
